WTX-1011
/ Werewolf Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 04, 2025
WTX-1011: Preclinical data demonstrated that PREDATOR masking technology successfully silenced peripheral activity and prevented cytokine release.
(The Manila Times)
- "Werewolf expects to nominate a differentiated target candidate in the fourth quarter of 2025."
Pipeline update • Preclinical • Prostate Cancer
1 to 1
Of
1
Go to page
1